10x Genomics Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
10x Genomics (TXG) Misses Q3 EPS by 35c, Revenues Beat
November 10, 2020 4:25 PM EST10x Genomics (NASDAQ: TXG) reported Q3 EPS of ($0.65), $0.35 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $71.8 million versus the consensus estimate of $61.23 million.
Recent Highlights
Revenue was $71.8 million for the third quarter, representing a 17% increase over the... More